Market Trends of Italy Diagnostic Imaging Equipment Industry
This section covers the major market trends shaping the Italy Diagnostic Imaging Equipment Market according to our research experts:
Oncology Segment is Expected to Show Better Growth in the Forecast Years
The oncology segment is expected to witness growth over the forecast period owing to the factors such as the high prevalence of cancer cases and technological advancements in the cancer diagnostic field in Italy. Oncology deals with the diagnosis and treatment of tumors and cancers, which is one the leading causes of morbidity and mortality. According to Globocan 2020 report, among both sexes, breast, colorectum, and prostate cancers were among the most common cancers in Italy, with breast cancer alone contributing to more than 13.3% of the total new cases. The diagnostic test majorly adopted for breast cancer is the mammogram, the chance of adoption of a such diagnostic test in Italy is likely to be high. Furthermore, diagnostic imaging plays a vital role in interventional oncology with rising opportunities to diagnose and treat in a minimally invasive manner, which is expected to drive the market growth.
Furthermore, the presence of competitors, mergers, acquisitions, and collaboration in the studied area boosts the market growth. For instance, as per the 2021 report, Affidea, the largest European provider of diagnostic imaging, outpatient, and cancer care services continued to invest in the Italian market and announced the 100% acquisition of Medical Sport Center and Medical Center, two flagship medical centers in Lodi, Lombardy region, a densely populated area of 230.000 inhabitants. This transaction was the 20th in the last two years made by Affidea Group in alignment with a successful growth strategy consolidating its leadership position across 15 countries in Europe. With this acquisition, both the companies were adding new outpatient capabilities and adjacent services, synergetic with the other Affidea centers, which was likely to allow them to offer larger access for patients to best-in-class integrated services at the highest standards of quality and safety.
Hence as per the aforementioned factors, the Oncology segment is likely to face growth over the forecast period.
